期刊文献+

活血安心汤治疗不稳定型心绞痛的临床疗效观察

下载PDF
导出
摘要 目的:观察并探讨自拟的活血安心汤治疗不稳定型心绞痛的临床疗效。方法:将我院2008年11月~2010年8月收治的126例不稳定型心绞痛患者随机分为观察组62例、对照组64例。两组患者均给予不稳定型心绞痛常规西药治疗,观察组在此基础上另服活血安心汤。2周后比较两组临床治疗效果及副作用情况。结果:观察组总有效率为77.42%;对照组总有效率为51.56%。两组总有效率比较有显著性统计学意义(x2=9.17,P<0.05)。治疗过程中两组均未见明显不良反应,也未曾诱发出现急性心肌梗死。两组药物副作用发生率比较无显著性差异(x2=1.16,P>0.05)。结论:活血安心汤治疗不稳定型心绞痛临床疗效显著,不良反应少,可于临床进一步应用。
作者 吕讳贤
出处 《医学信息(中旬刊)》 2011年第2期666-666,共1页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献4

二级参考文献28

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2陶霞.冠心宁治疗不稳定型心绞痛疗效观察[J].河南中医,2007,27(7):32-32. 被引量:5
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374. 被引量:1
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840. 被引量:1
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176. 被引量:1
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339. 被引量:1
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502. 被引量:1
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533. 被引量:1
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924. 被引量:1
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505. 被引量:1

共引文献2236

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部